Barr Ellison Solicitors – commercial property
Advertisement: RSM
Advertisement: EBCam mid banner
Advertisement: Mogrify
ARM Innovation Hub
Advertisement: EY Mid banner
Advertisement: Simpsons Creative
RealVNC mid-banner general
Mid banner advertisement: BDO
RealVNC mid banner careers
Advertisement: China mid banner
Advertisement: Cambridge Network
22 April, 2020 - 11:28 By Kate Sweeney

Diamond Pharma sparkles with key acquisition

Diamond Pharma Services in Harlow, a leading technical services and regulatory affairs consulting group, has further strengthened its position in Europe via a significant acquisition.

Its pharmacovigilance division, Diamond PV Services, has bought PharmaCentral – a pharmacovigilance services and medical affairs business based in Dublin. No figures have been released for the deal.

As well as expanding Diamond’s presence in Europe the move will enhance the senior-level expertise within its pharmacovigilance team.

PharmaCentral offers a wide range of pharmacovigilance consultancy services based on a wealth of experience in pharmacovigilance and medical affairs in both pharma and CRO environments. 

The acquisition forms part of Diamond’s growth strategy for the division, which has achieved a Compound Annual Growth Rate (CAGR) in revenues of 27 per cent over the last three years.

This rapid expansion of Diamond’s pharmacovigilance senior level team is required to support clients from the group’s regulatory affairs business in specialist areas such as gene and cell therapies.

Diamond Pharma Services provides Regulatory Affairs, Pharmacovigilance and Compliance & Quality services to support pharmaceutical and biotechnology companies in obtaining and maintaining medicinal product licences throughout all stages of a product’s life cycle. 

Diamond will continue to expand its presence in Dublin through 2020 with recruitment across all three of its divisions. 

David Boyd, managing director, Diamond PV Services, said: “We have seen strong organic growth over the last three years which has driven us to evaluate our resources, including our in-house expertise, processes and systems. 

“This acquisition will help support the next phase of growth, representing a step change in our senior team. Having worked closely with PharmaCentral over the past year I am confident that they share our culture of flexibility, quality and accessibility, and am hugely excited that they are joining Diamond to deliver our shared vision of helping our clients manage their regulatory responsibilities in a constantly evolving environment.”

Newsletter Subscription

Stay informed of the latest news and features